Literature DB >> 8929351

Localization of histidyl-tRNA synthetase (Jo-1) in human laryngeal epithelial carcinoma cell line (HEp-2 cells).

D Vázquez-Abad1, J H Carson, N Rothfield.   

Abstract

The present study was designed to determine the subcellular localization of histidyl-tRNA synthetase (Jo-1) in human laryngeal epithelial carcinoma cell line (HEp-2 cells). Indirect immunofluorescence using commercial HEp-2 cells with human serum and human-affinity-purified anti-Jo-1 antibodies was performed using confocal microscopy. Anti-histidyl-tRNA-synthetase-positive sera showed distinct nuclear and cytoplasmic granular staining in HEp-2 cells. Affinity purified anti-Jo-1 produced an identical pattern to the whole serum, whereas the serum fraction that did not bind to the affinity column was negative by immunofluorescence on HEp-2 cells. Two commercial human anti-Jo-1-positive control sera and seven anti-Jo-1-positive sera from patients with myositis reproduced the nuclear and cytoplasmic granular pattern. We conclude that Jo-1 is present in cytoplasm and in intact nuclei from HEp-2 cells. The presence of tRNA synthetases in intact nuclei suggests that they have an unsuspected function in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929351     DOI: 10.1007/s004410050718

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  3 in total

1.  Anti-Ro52 antibodies, antisynthetase antibodies, and antisynthetase syndrome.

Authors:  Vidya S Limaye; John Cassidy; Grace Scott; Peter J Roberts-Thomson; David Gillis
Journal:  Clin Rheumatol       Date:  2007-10-11       Impact factor: 2.980

2.  Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies.

Authors:  Goran Bajic; Cees E van der Poel; Masayuki Kuraoka; Aaron G Schmidt; Michael C Carroll; Garnett Kelsoe; Stephen C Harrison
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

Review 3.  Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Diego Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-07       Impact factor: 10.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.